Details of the Drug Reposition

General Information of This Drug (ID: DMIU1HY)

Drug Name
HuM-195-Ac-225   DMIU1HY
Synonyms HuM-195 [225Ac]; SMART 225Ac-M195; Actinium-225-M195; SMART actinium-225-M195; Actinium-225-HuM-195; 225Ac-HuM-195; 225Ac-lintuzumab

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute myelogenous leukaemia DISCSPTN 2A41 Phase 1/2 [1]
Acute myeloid leukaemia DIS0BM1I 2A60 Phase 1/2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of Actinium Pharmaceuticals.